BIOMERICA (BMRA) Stock: Buy, Sell, or Hold?
BMRA - BIOMERICA INC
$2.24
0.01 (0.45%)
▲
5d:
+0.9%
30d:
+42.68%
90d:
+7.18%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 13, 2026
30d
Get Alerted When BMRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BMRA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BMRA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BMRA is currently trading at $2.24, which is considered extended relative to its 30-day fair value range of $1.54 to $2.14.
Technical Outlook: Technically, BMRA is in a downtrend. Immediate support is located at $1.94, while resistance sits at $2.38.
Market Sentiment: BMRA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+480.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BMRA is in a downtrend. Immediate support is located at $1.94, while resistance sits at $2.38.
Market Sentiment: BMRA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+480.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.54 -
$2.14
Company Quality Score
30/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: Trading 480.4% below Wall St target ($13.00)
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.54 -
$2.14
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.94
Resistance Level
$2.38
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Wall Street Target
$13.00
(+480.4%)
Revenue Growth (YoY)
16.8%
Profit Margin
-84.8%
Share & Embed Analysis
Last updated: September 12, 2026 12:05 PM ET
Data refreshes hourly during market hours. Next update: 1:05 PM
Data refreshes hourly during market hours. Next update: 1:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
